AstraZeneca Sees Off Shareholder Revolt Over CEO’s Potential $25m Pay

Investors Upbeat Despite Vaccine Woes

 
• By Andrew McConaghie
  
Pascal Soriot
Soriot is criticized by EU leaders for failing to deliver enough COVID-19 vaccine doses, but is also credited for turning around AZ's fortunes. • Source: Alamy

More from Business

More from Scrip